Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 19, 2016, Pages 3992-3996

  Jing, S Y ^a   Lu, Y Y ^b   Yang, J K ^a   Deng, W Y ^b   Zhou, Q ^b   Jiao, B H ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Wuhan Medical and Healthcare Center for Woman and Children   (China)

Author keywords

Glioma; LncRNA CRNDE; Overall survival; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA CRNDE; UNCLASSIFIED DRUG; CRNDE RNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; BRAIN TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; PROGNOSIS; TUMOR RECURRENCE;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RNA, LONG NONCODING;

EID: 85016419852     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. SATHORNSUMETEE S, RICH JN. New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 2006; 6: 1087-1104.
2. LOUIS DN, OHGAKI H, WIESTLER OD, CAVENEE WK, BURGER PC, JOUVET A, SCHEITHAUER BW, KLEIHUES P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109
3. OHGAKI H, KLEIHUES P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005; 109: 93-108.
4. YOON JH, ABDELMOHSEN K, GOROSPE M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol 2013; 425: 3723-3730.
5. ZHAO W, AN Y, LIANG Y, XIE XW. Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur Rev Med Pharmacol Sci 2014; 18: 1930-1936.
6. KHALIL AM, GUTTMAN M, HUARTE M, GARBER M, RAJ A, RIVEA MORALES D, THOMAS K, PRESSER A, BERNSTEIN BE, VAN OUDENAARDEN A, REGEV A, LANDER ES, RINN JL. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009; 106: 11667-11672.
7. TUO YL, LI XM, LUO J. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR- 143. Eur Rev Med Pharmacol Sci 2015; 19: 3403-3411.
8. ZHEN L, LIU YH, DIAO HY, JUN M, YAO YL. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumour Biol 2016; 37: 673-683.
9. ZHANG K, SUN X, ZHOU X, HAN L, CHEN L, SHI Z, ZHANG A, YE M, WANG Q, LIU C, WEI J, REN Y, YANG J, ZHANG J, PU P, LI M, KANG C. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget 2015; 6: 537-546.
10. WU L, LI G, FENG D, QIN H, GONG L, ZHANG J, ZHANG Z. MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol 2013; 8: 200.
11. QU DW, XU HS, HAN XJ, WANG YL, OUYANG CJ. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance. Eur Rev Med Pharmacol Sci 2014; 18: 516-519.
12. LI W, XIE P, RUAN WH. Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis. J Bone Oncol 2016; 5: 80-85.
13. MA KX, WANG HJ, LI XR, LI T, SU G, YANG P, WU JW. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol 2015; 36: 3355-3359.
14. KIANG KM, ZHANG XQ, LEUNG GK. Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis. Cancers (Basel) 2015; 7: 1406-1424.
15. SZAFRON LM, BALCERAK A, GRZYBOWSKA EA, PIENKOWSKA- GRELA B, PODGORSKA A, ZUB R, OLBRYT M, PAMULAPILAT J, LISOWSKA KM, GRZYBOWSKA E, RUBEL T, DANSONKA- MIESZKOWSKA A, KONOPKA B, KULESZA M, LUKASIK M, KUPRYJANCZYK J. The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients. Oncotarget 2015; 6: 43897-43910.
16. WANG Y, WANG Y, LI J, ZHANG Y, YIN H, HAN B. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett 2015; 367: 122-128.
17. ZHENG J, LI XD, WANG P, LIU XB, XUE YX, HU Y, LI Z, LI ZQ, WANG ZH, LIU YH. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget 2015; 6: 25339-25355.